Skip to content

Ubie, Japanese HealthTech Startup, Launches AI-powered Symptom Checker in U.S.

By asianet

– Trusted by 4.5 Million Monthly Users Worldwide – Ubie, Inc., a healthcare AI startup with the mission “To develop a healthcare guide for everyone,” has launched in the United States an “AI-powered symptom checker” ( https://ubiehealth.com ) that allows users to enter symptoms and discover related diseases. Image: https://kyodonewsprwire.jp/prwfile/release/M107009/202204180106/_prw_PI1fl_e08qVvYw.png Ubie, founded in Japan in … Continued

Sumitomo Pharma takes license to CRISPR/Cas9 patent portfolio from ERS Genomics

By asianet

ERS Genomics Limited (“ERS”) is pleased to confirm finalization of a license agreement with Sumitomo Pharma Co., Ltd. (“Sumitomo Pharma”) granting Sumitomo Pharma non-exclusive access to the fundamental CRISPR/Cas9 intellectual property portfolio held by ERS. ERS, co-founded by Dr. Emmanuelle Charpentier, 2020 Nobel Prize winner for gene-editing, provides access to the foundational CRISPR/Cas9 intellectual property. … Continued

Confusing health requirements are stopping passengers from flying

By asianet

An international survey of people in the United States, the United Kingdom, Italy, and the Gulf reveals widespread confusion around health requirements for air travel, and fears that the aviation sector is not prepared for another global health crisis – Many people in every country surveyed say they chose not to fly in 2021 because … Continued

Terran Biosciences announces licensing deal with Sanofi for two late-stage CNS pipeline assets

By asianet

— Terran to advance the development of two of Sanofi’s Phase 3 CNS therapeutics — Transaction includes worldwide exclusive rights for development and commercialization in all fields of use Terran Biosciences, Inc. (“Terran”), a biotech platform company dedicated to the development of transformational therapeutics for neurological and psychiatric diseases, has entered into an agreement with … Continued

Nippon Express Obtains IATA CEIV Pharma Certification for Temperature-controlled Facility at Kansai International Airport

By asianet

Nippon Express Co., Ltd. (hereinafter “Nippon Express”), a group company of Nippon Express Holdings, Inc., has obtained IATA CEIV Pharma (*) pharmaceutical transport quality certification, effective April 5, for its temperature-controlled facility “NX-PHARMA Logistics Hub Kansai Airport” located inside the international cargo area of Kansai International Airport. Logo: https://kyodonewsprwire.jp/img/202204190123-O3-n3Z45H8m Nippon Express has been participating in … Continued

Novavax Announces Approval of Nuvaxovid(TM) COVID-19 Vaccine for Primary and Booster Immunization in Japan

By asianet

— Nuvaxovid is the first protein-based COVID-19 vaccine approved for use in adults aged 18 and older in Japan — Approval is first in the world for NVX-CoV2373 that includes both primary and booster vaccination Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced … Continued

SMART Medical Systems’ G-EYE (R) Colonoscope is now FDA Cleared on Olympus’ PCF Colonoscope Series, Making it Available in the United States on the Commonly Used Models of All Leading Endoscopy Brands

By asianet

– FDA has approved the use of G-Eye (R) with Olympus’ 510(k) cleared PCF colonoscopes – SMART Medical Systems Ltd., a developer and manufacturer of innovative endoscopy products, today announced an additional FDA clearance for its G-EYE (R) Colonoscope, based on Olympus’ 510(k) cleared PCF colonoscope series. With this additional FDA clearance, G-EYE (R) is … Continued

Gastroenterology: NTC submits marketing authorisation application for KLEERKOL (R) in EU

By asianet

NTC Srl, R&D driven pharmaceutical company with headquarters in Italy announces the submission of the marketing authorisation application through the European Decentralised Procedure (DCP) for its development product NTC015 (Kleerkol(R)) for bowel preparation for colonoscopy. “Colonoscopy remains the standard for diagnosing and monitoring colorectal cancer and for diagnosis and surveillance of inflammatory bowel disease”, says … Continued

Translumina Launches VIVO ISAR, its Dual-Drug Polymer-free Coated Stent (DDCS) in International markets

By asianet

– Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company’s global growth journey Translumina, a global developer and manufacturer of innovative cardiovascular medical devices used in interventional cardiology, announces the launch of VIVO ISAR, its latest generation dual drug polymer-free coated stent (DDCS), in various International markets … Continued